About CML Colorectal Cancer


The educational mission of Current Medical Literature – Colorectal Cancer is to provide oncologists and allied healthcare professionals with access to expert commentary and analysis on topical, clinically relevant, and practical issues in the field of colorectal cancer. CML – Colorectal Cancer contains in-depth review articles written by international experts providing insight into specific educational themes with clearly defined learning objectives. All articles undergo rigorous peer-review prior to being accepted for publication. Each issue also contains critical reviews of the recently published articles of most importance and relevance written by practicing oncologists.

Leading Articles: Our Leading Articles are in-depth reviews commissioned from renowned experts. They are written to provide insight into specific educational themes identified through collaboration with the journal's Editorial Board and the CML editorial team. The topics are chosen in response to advances in the understanding, treatment, and management of patients, taking into account suggestions and feedback from readers and aiming to anticipate important issues arising in the field.

Clinical Reviews: The editors of CML – Colorectal Cancer identify the articles of most importance and relevance published in the international literature each quarter. They then prepare concise and critical analyses of these articles, discussing the research findings and explaining the importance of the results in a clinical context.

Editorial control is the responsibility of the Editorial Advisory Board, the Clinical Editors and the publisher. Before publication, all material submitted to the journal is subjected to rigorous review by the Editorial Advisory Board, Clinical Editors, and/or independent reviewers for suitability of scientific content, scientific accuracy, scientific quality, and conflict of interest.

The Current Medical Literature team would like to thank the following publishers for granting us access to their online journal content:
JAMA and the Archives journals
The New England Journal of Medicine

The Editors look forward to receiving suggestions from readers regarding current papers they think deserve to be featured and which may have been omitted, and on any matter which might improve the series.

Please address all correspondence to:
Current Medical Literature, Remedica Education and Publishing, Commonwealth House, 1 New Oxford Street, London WC1A 1NU, UK, Tel: +44 (0)20 7759 2999, Fax: +44 (0)20 7759 2951, Email: info@remedicajournals.com

Editor: Kirsten Miles
Editorial Manager:  Emma Beagley
Editorial Director: Scott Millar
Production Controller: Marie Ingram
Design and Artwork: AS&K Skylight Creative Services

Publisher’s Statement
© Remedica 20062011. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. Articles published here may have previously been published in The International Journal of Clinical Reviews, www.ijocr.com. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the manufacturer’s prescribing information.

ISSN 1364–4831 (Print)
ISSN 1759-8079 (Online)


Colorectal Cancer 3
Which imaging technique do you consider to be the most effective in the clinical staging of colorectal cancer?

Powered by NetPolls